|View printer-friendly version|
|Emergent BioSolutions to Present at the Thomas Weisel Partners Healthcare Conference 2007|
ROCKVILLE, Md.--(BUSINESS WIRE)--Aug. 20, 2007--Emergent BioSolutions Inc. (NYSE:EBS), a biopharmaceutical company focused on developing, manufacturing and commercializing immunobiotics to prevent or treat disease, announced today that it will present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007 at 2:05 pm Eastern Time at the Four Seasons Hotel, Boston.
Senior management of Emergent BioSolutions will provide a corporate overview including a discussion of the company's product development programs and recent corporate activities.
A webcast of the presentation will be available both live and by replay. To access both the live and archived webcast, please go to www.emergentbiosolutions.com, click on the "Investors" link and proceed to the "Webcasts & Presentations" section. The archived replay will be available 24 hours after the live presentation and will be accessible for 30 days.
CONTACT: Emergent BioSolutions Inc. Investors Contact: Robert G. Burrows, Vice President, Investor Relations 301-795-1877 email@example.com SOURCE: Emergent BioSolutions Inc.